Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, August 18, 2023.
Nemaura Medical received regulatory approval in the Middle East for its sugarBEAT sensor for glucose monitoring. The regulatory win comes after it received a provisional purchase order for more than 1 million sensors and thousands of devices. Fast Five hosts Sean Whooley and Danielle Kirsh go over what the sugarBEAT sensor is and some of the other regulatory agencies the company is hoping to gain approval from soon.
BlueWind Medical recently won an FDA do novo nod for its Revi neuromodulation system. Revi treats symptoms of incontinence. Learn about the device’s design and what doctors think about its use in today’s episode.
ZimVie wants to focus on diversifying its spine and trauma navigation technologies – and it plans to do that through its recently expanded development deal with Brainlab. Whooley shares the details of what the entire goal of the deal is and what executives are saying.
TransMedics recently completed the acquisition of Summit Aviation. This isn’t the typical medtech company buys medtech company acquisition, but the company has big plans. Find out why TransMedical purchased an aviation portfolio and how leadership will be handled upon completion of the deal.
Layoffs are still taking place in the medtech industry. This time, ICU Medical is tightening the belt and closing one of its facilities. Whooley explains why the company is closing one of its plants and how many employees are affected by the change in manufacturing operations.
Subscribe to the Fast Five daily news podcast on your preferred listening platform. If you’re on a desktop computer, scan the QR code below with your smartphone to easily access the podcast on your mobile device.
Listen to previous episodes here.
